NCT00281645View on ClinicalTrials.gov

Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

1,250

Participants

Timeline

Start Date

December 31, 2004

Conditions
Chronic Low Back Pain
Interventions
DRUG

Bicifadine

DRUG

Standard of Care (pharmacological analgesic treatment)

Sponsors
All Listed Sponsors
lead

DOV Pharmaceutical, Inc.

INDUSTRY